Copyright Reports & Markets. All rights reserved.

Global Atrial Fibrillation Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Atrial Fibrillation Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Catheter Ablation
    • 1.3.3 Maze Surgery
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Atrial Fibrillation Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Surgical Centers
    • 1.4.4 Others
  • 1.5 Global Atrial Fibrillation Devices Market Size & Forecast
    • 1.5.1 Global Atrial Fibrillation Devices Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Atrial Fibrillation Devices Sales Quantity (2020-2031)
    • 1.5.3 Global Atrial Fibrillation Devices Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Atrial Fibrillation Devices Product and Services
    • 2.1.4 Abbott Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Atrial Fibrillation Devices Product and Services
    • 2.2.4 Boston Scientific Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 J&J
    • 2.3.1 J&J Details
    • 2.3.2 J&J Major Business
    • 2.3.3 J&J Atrial Fibrillation Devices Product and Services
    • 2.3.4 J&J Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 J&J Recent Developments/Updates
  • 2.4 Medtronic
    • 2.4.1 Medtronic Details
    • 2.4.2 Medtronic Major Business
    • 2.4.3 Medtronic Atrial Fibrillation Devices Product and Services
    • 2.4.4 Medtronic Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Medtronic Recent Developments/Updates
  • 2.5 Japan Lifeline
    • 2.5.1 Japan Lifeline Details
    • 2.5.2 Japan Lifeline Major Business
    • 2.5.3 Japan Lifeline Atrial Fibrillation Devices Product and Services
    • 2.5.4 Japan Lifeline Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Japan Lifeline Recent Developments/Updates
  • 2.6 AtriCure
    • 2.6.1 AtriCure Details
    • 2.6.2 AtriCure Major Business
    • 2.6.3 AtriCure Atrial Fibrillation Devices Product and Services
    • 2.6.4 AtriCure Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 AtriCure Recent Developments/Updates
  • 2.7 Biotronik
    • 2.7.1 Biotronik Details
    • 2.7.2 Biotronik Major Business
    • 2.7.3 Biotronik Atrial Fibrillation Devices Product and Services
    • 2.7.4 Biotronik Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biotronik Recent Developments/Updates
  • 2.8 Philips
    • 2.8.1 Philips Details
    • 2.8.2 Philips Major Business
    • 2.8.3 Philips Atrial Fibrillation Devices Product and Services
    • 2.8.4 Philips Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Philips Recent Developments/Updates
  • 2.9 Synaptic Medical
    • 2.9.1 Synaptic Medical Details
    • 2.9.2 Synaptic Medical Major Business
    • 2.9.3 Synaptic Medical Atrial Fibrillation Devices Product and Services
    • 2.9.4 Synaptic Medical Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Synaptic Medical Recent Developments/Updates
  • 2.10 Osypka AG
    • 2.10.1 Osypka AG Details
    • 2.10.2 Osypka AG Major Business
    • 2.10.3 Osypka AG Atrial Fibrillation Devices Product and Services
    • 2.10.4 Osypka AG Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Osypka AG Recent Developments/Updates
  • 2.11 MicroPort Scientific
    • 2.11.1 MicroPort Scientific Details
    • 2.11.2 MicroPort Scientific Major Business
    • 2.11.3 MicroPort Scientific Atrial Fibrillation Devices Product and Services
    • 2.11.4 MicroPort Scientific Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 MicroPort Scientific Recent Developments/Updates
  • 2.12 CardioFocus
    • 2.12.1 CardioFocus Details
    • 2.12.2 CardioFocus Major Business
    • 2.12.3 CardioFocus Atrial Fibrillation Devices Product and Services
    • 2.12.4 CardioFocus Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 CardioFocus Recent Developments/Updates
  • 2.13 Lepu Medical
    • 2.13.1 Lepu Medical Details
    • 2.13.2 Lepu Medical Major Business
    • 2.13.3 Lepu Medical Atrial Fibrillation Devices Product and Services
    • 2.13.4 Lepu Medical Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Lepu Medical Recent Developments/Updates
  • 2.14 APT Med
    • 2.14.1 APT Med Details
    • 2.14.2 APT Med Major Business
    • 2.14.3 APT Med Atrial Fibrillation Devices Product and Services
    • 2.14.4 APT Med Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 APT Med Recent Developments/Updates
  • 2.15 TZ Medical
    • 2.15.1 TZ Medical Details
    • 2.15.2 TZ Medical Major Business
    • 2.15.3 TZ Medical Atrial Fibrillation Devices Product and Services
    • 2.15.4 TZ Medical Atrial Fibrillation Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 TZ Medical Recent Developments/Updates

3 Competitive Environment: Atrial Fibrillation Devices by Manufacturer

  • 3.1 Global Atrial Fibrillation Devices Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Atrial Fibrillation Devices Revenue by Manufacturer (2020-2025)
  • 3.3 Global Atrial Fibrillation Devices Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Atrial Fibrillation Devices by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Atrial Fibrillation Devices Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Atrial Fibrillation Devices Manufacturer Market Share in 2024
  • 3.5 Atrial Fibrillation Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Atrial Fibrillation Devices Market: Region Footprint
    • 3.5.2 Atrial Fibrillation Devices Market: Company Product Type Footprint
    • 3.5.3 Atrial Fibrillation Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Atrial Fibrillation Devices Market Size by Region
    • 4.1.1 Global Atrial Fibrillation Devices Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Atrial Fibrillation Devices Consumption Value by Region (2020-2031)
    • 4.1.3 Global Atrial Fibrillation Devices Average Price by Region (2020-2031)
  • 4.2 North America Atrial Fibrillation Devices Consumption Value (2020-2031)
  • 4.3 Europe Atrial Fibrillation Devices Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Atrial Fibrillation Devices Consumption Value (2020-2031)
  • 4.5 South America Atrial Fibrillation Devices Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Atrial Fibrillation Devices Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 5.2 Global Atrial Fibrillation Devices Consumption Value by Type (2020-2031)
  • 5.3 Global Atrial Fibrillation Devices Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 6.2 Global Atrial Fibrillation Devices Consumption Value by Application (2020-2031)
  • 6.3 Global Atrial Fibrillation Devices Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 7.2 North America Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 7.3 North America Atrial Fibrillation Devices Market Size by Country
    • 7.3.1 North America Atrial Fibrillation Devices Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Atrial Fibrillation Devices Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 8.2 Europe Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 8.3 Europe Atrial Fibrillation Devices Market Size by Country
    • 8.3.1 Europe Atrial Fibrillation Devices Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Atrial Fibrillation Devices Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Atrial Fibrillation Devices Market Size by Region
    • 9.3.1 Asia-Pacific Atrial Fibrillation Devices Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Atrial Fibrillation Devices Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 10.2 South America Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 10.3 South America Atrial Fibrillation Devices Market Size by Country
    • 10.3.1 South America Atrial Fibrillation Devices Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Atrial Fibrillation Devices Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Atrial Fibrillation Devices Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Atrial Fibrillation Devices Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Atrial Fibrillation Devices Market Size by Country
    • 11.3.1 Middle East & Africa Atrial Fibrillation Devices Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Atrial Fibrillation Devices Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Atrial Fibrillation Devices Market Drivers
  • 12.2 Atrial Fibrillation Devices Market Restraints
  • 12.3 Atrial Fibrillation Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Atrial Fibrillation Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Atrial Fibrillation Devices
  • 13.3 Atrial Fibrillation Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Atrial Fibrillation Devices Typical Distributors
  • 14.3 Atrial Fibrillation Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Atrial Fibrillation Devices market size was valued at US$ 3652 million in 2024 and is forecast to a readjusted size of USD 7291 million by 2031 with a CAGR of 10.5% during review period.
    Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF.
    The atrial fibrillation devices market is driven by the rising prevalence of atrial fibrillation (AF) globally, particularly due to an aging population and the increasing incidence of lifestyle-related risk factors such as hypertension, obesity, and diabetes. The growing demand for minimally invasive treatments, such as catheter ablation and cardiac monitors, has spurred innovation and adoption of advanced AF devices. Additionally, technological advancements, such as improved mapping and navigation systems for precise treatment, are enhancing the effectiveness of these devices and contributing to market growth.
    A significant challenge in the atrial fibrillation devices market is the high cost of advanced devices and procedures, which can limit access to treatment, especially in low-income regions. Reimbursement issues and lack of affordability can prevent many patients from receiving timely care. Additionally, the complexity of some procedures, such as catheter ablation, requires specialized training for healthcare providers, which can limit the availability of skilled professionals, particularly in developing countries. Furthermore, the risk of complications associated with AF devices, such as blood clots or infection, may hinder patient acceptance and market expansion.
    The leading manufacturers of atrial fibrillation devices include Abbott, Boston Scientific, Biosense Webster, etc, with the top 2 accounting for about 60%. North America is the largest market with about 37%, followed by Europe with about 27%.In terms of product, catheter ablation is the largest segment, with a share over 88%. And in terms of application, the largest application is ambulatory surgical centers, followed by hospitals.
    This report is a detailed and comprehensive analysis for global Atrial Fibrillation Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Atrial Fibrillation Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Atrial Fibrillation Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Atrial Fibrillation Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Atrial Fibrillation Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Atrial Fibrillation Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Atrial Fibrillation Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, J&J, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips, Synaptic Medical, Osypka AG, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Atrial Fibrillation Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Catheter Ablation
    Maze Surgery
    Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others
    Major players covered
    Abbott
    Boston Scientific
    J&J
    Medtronic
    Japan Lifeline
    AtriCure
    Biotronik
    Philips
    Synaptic Medical
    Osypka AG
    MicroPort Scientific
    CardioFocus
    Lepu Medical
    APT Med
    TZ Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Atrial Fibrillation Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Atrial Fibrillation Devices, with price, sales quantity, revenue, and global market share of Atrial Fibrillation Devices from 2020 to 2025.
    Chapter 3, the Atrial Fibrillation Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Atrial Fibrillation Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Atrial Fibrillation Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Atrial Fibrillation Devices.
    Chapter 14 and 15, to describe Atrial Fibrillation Devices sales channel, distributors, customers, research findings and conclusion.

    Buy now